James Hurst, based in Kirkland & Ellis LLP‘s Chicago office, is often called upon by major pharmaceutical clients facing claims ranging from product liability cases to IP infringement suits. In Whitfield v. Abbott, et al., Hurst secured a jury verdict for Abbott in a $5.2bn plaintiff suit, which alleged that the defendant’s infant formula products caused necrotizing enterocolitis.
Legal 500 Editorial commentary
Phone
+1 312-862-5230
Email
Profile

Profile

Position

Jim Hurst is a trial lawyer who serves on Kirkland’s Executive Committee. He’s been trying cases for 30 years, including patent, products liability, trade secret, antitrust, fraud, and contract cases. He's also argued dozens of appeals including before the U.S. Supreme Court. He’s was named Benchmark’s “Trial Lawyer of the Year” in 2018, and is one of only three lawyers honored twice in The American Lawyer’s biannual "Litigator of the Year” contest—the first for eight straight trial wins and the second for six straight trial wins. His trial wins are regularly reported in the press, including a 2019 American Lawyer articled entitled “Kirkland’s Hurst Wins, And Then He Wins Some More--How Does He Do It?”

Education

University of Pennsylvania Law School, J.D., 1989 cum laude; University of Delaware, B.S., 1986 magna cum laude

Content supplied by Kirkland & Ellis LLP